During the Microbiome Connect Europe conference, held early in July in Amsterdam, Microbiomepost sat down with Jean-Luc Marsat, CEO & Chairman at EverImmune, to discuss the research EverImmune carries out in oncology.
Live Biotherapeutics as cancer treatments: scientific and regulatory challenges
Staff editor
20.09.2023
Jean-Luc Marsat, CEO & Chairman at EverImmune, discusses the research EverImmune carries out in oncology.
Latest related content
Endocrinology, Nutrition
Healthcare professionals area, Neuroscience
Healthcare professionals area
Latest News
Endocrinology, Nutrition
Healthcare professionals area, Neuroscience
Healthcare professionals area